1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7.
Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5.
Overview of Market
Drivers, Challenges, Trends
4. Voice of Customer
5.
Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Application
5.7. Breakdown of Pipeline, By Region
5.8.
Clinical Trials Heat
Map
6.
Global Topical Drug Delivery Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By
Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations,
Transdermal Products)
6.2.2. By Route of Administration (Dermal Drug Delivery,
Ophthalmic Drug Delivery, Rectal Drug Delivery, Nasal Drug Delivery)
6.2.3. By End-User (Hospitals, Clinics, Home Healthcare,
Diagnostic Centers, Others)
6.2.4.
By Company (2022)
6.2.5. By Region (North America, Europe,
Asia-Pacific, South America, Middle East & Africa)
6.3. Product Market Map
7.
North America Topical Drug Delivery Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Route of Administration
7.2.3. By End User
7.2.4. By Country (United States; Canada; Mexico)
7.3. North America: Country Analysis
7.3.1. United States Topical Drug Delivery Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Route of
Administration
7.3.1.2.3.
By End User
7.3.1.2.4.
By Distribution
Channel
7.3.2. Canada Topical Drug Delivery Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Route of
Administration
7.3.2.2.3.
By End User
7.3.3. Mexico Topical Drug Delivery Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Route of
Administration
7.3.3.2.3.
By End User
8.
Europe Topical Drug Delivery Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Route of Administration
8.2.3. By End User
8.2.4. By Country (France; Germany; UK; Italy; Spain)
8.3. Europe: Country Analysis
8.3.1. France Topical Drug Delivery Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Route of
Administration
8.3.1.2.3.
By End User
8.3.2. Germany Topical Drug Delivery Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Route of
Administration
8.3.2.2.3.
By End User
8.3.3. United Kingdom Topical Drug Delivery Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Route of Administration
8.3.3.2.3.
By End User
8.3.4. Italy Topical Drug Delivery Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Route of
Administration
8.3.4.2.3.
By End User
8.3.5. Spain Topical Drug Delivery Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Route of
Administration
8.3.5.2.3.
By End User
9.
Asia-Pacific Topical Drug Delivery Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Route of Administration
9.2.3. By End User
9.2.4.
By Country (China; India; Japan; South Korea; Australia)
9.3. Asia-Pacific: Country Analysis
9.3.1. China Topical Drug Delivery Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Route of
Administration
9.3.1.2.3.
By End User
9.3.2. India Topical Drug Delivery Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Route of
Administration
9.3.2.2.3.
By End User
9.3.3. Japan Topical Drug Delivery Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Route of Administration
9.3.3.2.3.
By End User
9.3.4. South Korea Topical Drug Delivery Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Product
9.3.4.2.2.
By Route of
Administration
9.3.4.2.3.
By End User
9.3.5. Australia Topical Drug Delivery Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Product
9.3.5.2.2.
By Route of
Administration
9.3.5.2.3.
By End User
10.
Middle East and
Africa Topical
Drug Delivery Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Product
10.2.2. By Route of Administration
10.2.3. By End User
10.2.4. By Country (UAE; Saudi Arabia; South Africa)
10.3.
MEA: Country
Analysis
10.3.1. South Africa Topical Drug Delivery Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Route of
Administration
10.3.1.2.3.
By End User
10.3.2. Saudi Arabia Topical Drug Delivery Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Route of
Administration
10.3.2.2.3.
By End User
10.3.3. UAE Topical Drug Delivery Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Route of
Administration
10.3.3.2.3.
By End User
11.
South America Topical Drug Delivery Market Outlook
11.1.
Market Size &
Forecast
11.1.1. By Value
11.2.
Market Share &
Forecast
11.2.1. By Product
11.2.2. By Route of Administration
11.2.3. By End User
11.2.4. By Country (Brazil; Argentina; Colombia)
11.3.
South America:
Country Analysis
11.3.1. Brazil Topical Drug Delivery Market Outlook
11.3.1.1. Market Size &
Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share &
Forecast
11.3.1.2.1.
By Product
11.3.1.2.2.
By Route of
Administration
11.3.1.2.3.
By End User
11.3.2. Argentina Topical Drug Delivery Market Outlook
11.3.2.1. Market Size &
Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share &
Forecast
11.3.2.2.1.
By Product
11.3.2.2.2.
By Route of
Administration
11.3.2.2.3.
By End User
11.3.3. Colombia Topical Drug Delivery Market Outlook
11.3.3.1. Market Size &
Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share &
Forecast
11.3.3.2.1.
By Product
11.3.3.2.2.
By Route of
Administration
11.3.3.2.3.
By End User
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends &
Developments
13.1.
Recent Developments
13.2.
Mergers &
Acquisitions
13.3.
Product Developments
14. Competitive Landscape
14.1.
Business Overview
14.2.
Company Snapshot
14.3.
Products &
Services
14.4.
Financials (In case
of listed companies)
14.5.
Recent Developments
14.6.
SWOT Analysis
14.6.1. Johnson &
Johnson SA
14.6.2. Nestlé SA
14.6.3. GlaxoSmithKline Plc
14.6.4. Novartis AG
14.6.5. Merck & Co. Inc.
14.6.6. Crescita
Therapeutics Inc.
14.6.7. Cipla Ltd.
14.6.8. Taro Pharmaceutical
Industries Ltd.
14.6.9. Valeant Pharmaceuticals International Inc.
14.6.10.
Glenmark Pharmaceuticals Ltd.
15. Strategic Recommendations